Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company NephRx Corp.
DescriptionKidney growth factor peptide
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I
Standard IndicationRenal transplant rejection
Indication DetailsPrevent delayed graft function (DGF) after renal transplantation
Regulatory Designation U.S. - Orphan Drug (Prevent delayed graft function (DGF) after renal transplantation)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today